ETHEX issued a recall of its morphine sulfate pills last week after it was discovered that a likely manufacturing error caused some tablets to have twice their safe dosage. The risk of taking twice the recommended amount is opiate overdose which is potentially life threatening. Symptoms of an overdose include low blood pressure, difficulty breathing and anything else considered out of the ordinary, such as trouble maintaining consciousness and other symptoms consistent with the body shutting down.
The following lot numbers are involved in the recall:
Morphine Sulfate ER 30 mg Tablet/NDC #58177-320-04:
Lots 75090, 77846, 77847, 80048, 83320, 89661, 89665, 90252 through 90258, and 93284.
Morphine Sulfate ER 60 mg Tablet/NDC #58177-330-04:
Lots 91762, 75091, 75092, 77848 through 77851, 82517, 82518, 83333, 83817, 83862, 84111, 84112, 84315, 84900, 85326, 85335, 85807, 86270 through 86276, 87723, 87939, 88007, 89083, 89668, 89669, 89821, 90260 through 90272, and 91763 through 91765.
Mophine Sulfate is Schedule II narcotic that is a prescription drug that is used to control pain in people with moderate to sever pain management for the treatment of moderate to severe pain.
This is the second report of a manufacturer recall a prescription drug because it had twice the recommended dosage. Digitek, a drug for heart patients, was recalled last month because it is linked to digitalis toxicity resulting from pills that were twice the labeled dosage. How a mistake of this kind can pass though the quality assurance department of a drug company should be a concern to us all – and the FDA.
Accordingly, our Ethex morphine sulfate recall lawyers are reviewing these Ethex morphine overdose cases throughout the country for patients who have suffered serious injury or death. If you want to discuss your potential lawsuit with one of our Ethex morphine lawyers call us at 800-553-8082 for a free consultation.